These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18854759)

  • 1. Multiple sampling improves norepinephrine reproducibility in essential hypertension: a comparison with the microneurographic technique.
    Grassi G; Bolla GB; Seravalle G; Quarti-Trevano F; Facchetti R; Mancia G
    J Hypertens; 2008 Nov; 26(11):2185-90. PubMed ID: 18854759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproducibility patterns of plasma norepinephrine and muscle sympathetic nerve traffic in human obesity.
    Grassi G; Seravalle G; Dell'Oro R; Arenare F; Facchetti R; Mancia G
    Nutr Metab Cardiovasc Dis; 2009 Sep; 19(7):469-75. PubMed ID: 19157817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between reproducibility and sensitivity of muscle sympathetic nerve traffic and plasma noradrenaline in man.
    Grassi G; Bolla G; Seravalle G; Turri C; Lanfranchi A; Mancia G
    Clin Sci (Lond); 1997 Mar; 92(3):285-9. PubMed ID: 9093009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart rate as a sympathetic marker during acute adrenergic challenge.
    Grassi G; Seravalle G; Bolla G; Quarti-Trevano F; Dell'Oro R; Arenare F; Mancia G
    J Hypertens; 2008 Jan; 26(1):70-5. PubMed ID: 18090542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential sympathetic activation in muscle and skin neural districts in the metabolic syndrome.
    Grassi G; Quarti-Trevano F; Seravalle G; Dell'Oro R; Dubini A; Mancia G
    Metabolism; 2009 Oct; 58(10):1446-51. PubMed ID: 19515393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sympathetic nervous system in the pathogenesis of hypertension.
    Rahn KH; Barenbrock M; Hausberg M
    J Hypertens Suppl; 1999 Aug; 17(3):S11-4. PubMed ID: 10489093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noradrenaline spillover and microneurography measurements in patients with primary hypertension.
    Jennings GL
    J Hypertens Suppl; 1998 Aug; 16(3):S35-8. PubMed ID: 9747908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart rate as marker of sympathetic activity.
    Grassi G; Vailati S; Bertinieri G; Seravalle G; Stella ML; Dell'Oro R; Mancia G
    J Hypertens; 1998 Nov; 16(11):1635-9. PubMed ID: 9856364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sympathetic Nerve Traffic and Arterial Baroreflex Function in Apparent Drug-Resistant Hypertension.
    Dell'Oro R; Quarti-Trevano F; Seravalle G; Zanchettin F; Bertoli S; Airoldi F; Mancia G; Grassi G
    Hypertension; 2019 Oct; 74(4):903-909. PubMed ID: 31378103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating sympathetic activity in human hypertension.
    Mancia G; Grassi G; Parati G; Daffonchio A
    J Hypertens Suppl; 1993 Dec; 11(5):S13-9. PubMed ID: 8158309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic and neural effects of urapidil and prazosin in essential hypertensives.
    Grassi G; Seravalle G; Mancia G; Zanchetti A
    Blood Press Suppl; 1994; 4():13-8. PubMed ID: 7804507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efflux of nor-epinephrine from platelets in essential hypertension.
    Chandra N; Chandra M; Pandeya SN; Dhawan S; Soni D
    Indian Heart J; 1991; 43(6):461-3. PubMed ID: 1823895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of regional sympathetic nerve traffic in preascitic and ascitic cirrhosis.
    Pozzi M; Grassi G; Redaelli E; Dell'oro R; Ratti L; Redaelli A; Foglia G; Di Lelio A; Mancia G
    Hepatology; 2001 Dec; 34(6):1113-8. PubMed ID: 11732000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome.
    Quarti Trevano F; Seravalle G; Macchiarulo M; Villa P; Valena C; Dell'Oro R; Mancia G; Grassi G
    J Hypertens; 2017 Aug; 35(8):1685-1690. PubMed ID: 28350577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early sympathetic activation in the initial clinical stages of chronic renal failure.
    Grassi G; Quarti-Trevano F; Seravalle G; Arenare F; Volpe M; Furiani S; Dell'Oro R; Mancia G
    Hypertension; 2011 Apr; 57(4):846-51. PubMed ID: 21300663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of an L- and N-type calcium channel blocker in hypertensive patients with neurovascular compression of the rostral ventrolateral medulla.
    Aota Y; Morimoto S; Sakuma T; Morita T; Jo F; Takahashi N; Maehara M; Ikeda K; Sawada S; Iwasaka T
    Hypertens Res; 2009 Aug; 32(8):700-5. PubMed ID: 19521420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac dysautonomia and arterial distensibility in essential hypertensives.
    Acampa M; Franchi M; Guideri F; Lamberti I; Bruni F; Pastorelli M; Bova G; Pasqui AL; Puccetti L; Auteri A
    Auton Neurosci; 2009 Mar; 146(1-2):102-5. PubMed ID: 19121608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behaviour of regional adrenergic outflow in mild-to-moderate renal failure.
    Grassi G; Seravalle G; Arenare F; Buccianti G; Furiani S; Ilardo V; Bolla G; Mancia G
    J Hypertens; 2009 Mar; 27(3):562-6. PubMed ID: 19330916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of gender on the sympathetic nerve hyperactivity of essential hypertension.
    Hogarth AJ; Mackintosh AF; Mary DA
    J Hum Hypertens; 2007 Mar; 21(3):239-45. PubMed ID: 17167522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sympathetic activation in congestive heart failure: reproducibility of neuroadrenergic markers.
    Grassi G; Bolla G; Quarti-Trevano F; Arenare F; Brambilla G; Mancia G
    Eur J Heart Fail; 2008 Dec; 10(12):1186-91. PubMed ID: 18851926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.